Allakos Inc (ALLK)
0.76
-0.08
(-9.59%)
USD |
NASDAQ |
Jul 03, 16:00
0.7895
+0.03
(+3.88%)
Pre-Market: 09:09
Allakos Research and Development Expense (TTM): 152.65M for March 31, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 152.65M |
| December 31, 2023 | 150.91M |
| September 30, 2023 | 132.50M |
| June 30, 2023 | 114.18M |
| March 31, 2023 | 121.35M |
| December 31, 2022 | 265.08M |
| September 30, 2022 | 302.56M |
| June 30, 2022 | 327.68M |
| March 31, 2022 | 334.22M |
| December 31, 2021 | 196.33M |
| September 30, 2021 | 151.98M |
| June 30, 2021 | 138.80M |
| March 31, 2021 | 126.16M |
| Date | Value |
|---|---|
| December 31, 2020 | 105.53M |
| September 30, 2020 | 93.59M |
| June 30, 2020 | 79.28M |
| March 31, 2020 | 65.04M |
| December 31, 2019 | 61.86M |
| September 30, 2019 | 56.31M |
| June 30, 2019 | 48.95M |
| March 31, 2019 | 41.98M |
| December 31, 2018 | 33.29M |
| September 30, 2018 | 27.31M |
| June 30, 2018 | 23.93M |
| March 31, 2018 | 20.54M |
| December 31, 2017 | 18.51M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
56.31M
Minimum
Sep 2019
334.22M
Maximum
Mar 2022
156.63M
Average
132.50M
Median
Sep 2023
Research and Development Expense (TTM) Benchmarks
| Tonix Pharmaceuticals Holding Corp | 73.01M |
| RAPT Therapeutics Inc | 100.21M |
| NovaBay Pharmaceuticals Inc | 0.061M |
| Palatin Technologies Inc | 25.13M |
| iBio Inc | 6.401M |